Billy Kenber
Drug company profiteering exposed, The Times
Drug companies who preyed on the sick and vulnerable when they hiked prices for vital medicines by up to 12,500 per cent were exposed by a Times investigation whose impact will save the NHS hundreds of millions of pounds each year. Billy Kenbers campaigning articles – more than 20 over six months – triggered a change in the law, a regulatory inquiry expected to result in huge fines and the near-bankruptcy of a billion-dollar pharmaceutical firm. At a time when the NHS is under unprecedented financial strain, he revealed how a small group of profiteering companies had exploited a loophole in pricing rules to impose dramatic price increases costing taxpayers an extra £262 million a year. Urgent legislation tabled by the government in response will enable the NHS to impose new price limits.
Journalistic Writing and Social Media Content
- ‘Extortionate’ prices add £260m to NHS drug bill – The Times, 03/06/2016
- Drug ‘profiteers’ face fines – The Times, 04/06/2016
- Victory against ‘rip-off’ drug firms after Times investigaton – The Times, 16/09/2016
- Social Media Content
